Rescue inhalers on every 2026 New York Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in New York cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Assurance Rx$35.70/moS5617-013 | Wellcare Value Script$42.40/moS4802-138 | Wellcare Classic$45.70/moS4802-077 | HealthSpring Extra Rx$91.60/moS5617-353 | AARP Medicare Rx Saver from UHC$105.80/moS5921-379 | SilverScript Choice$116.00/moS5601-006 | Humana Basic Rx Plan$140.90/moS5884-216 | Humana Value Rx Plan$158.90/moS5884-218 | AARP Medicare Rx Preferred from UHC$163.70/moS5921-382 | Humana Premier Rx Plan$173.60/moS5884-217 |
|---|---|---|---|---|---|---|---|---|---|---|
| albuterol inhalergeneric ProAir / Ventolin | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Ventolin HFAalbuterol | Tier 325%QL 36/30d | Tier 325%QL 36/30d | Tier 325%QL 36/30d | Tier 317%QL 36/30d | Tier 317% | Not covered | Tier 325%QL 36/30d | Tier 317%QL 36/30d | Tier 315% | Tier 3$45.00QL 36/30d |
| ProAiralbuterol | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| levalbuterolgeneric Xopenex | Not covered | Tier 4PA40% | Not covered | Not covered | Not covered | Tier 2PA$6.00 | Not covered | Not covered | Tier 315% | Not covered |
| Airsupraalbuterol/budesonide | Not covered | Tier 325%QL 32.1/30d | Tier 325%QL 32.1/30d | Not covered | Tier 317%QL 32.1/30d | Tier 318%QL 32.1/30d | Not covered | Not covered | Tier 315%QL 32.1/30d | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.